Cargando…
Biological variation of ischaemia-modified albumin in healthy subjects
AIM: Ischaemia-modified albumin (IMA), as measured by the albumin-cobalt binding (ACB) test®, has been cleared by the US Food and Drug administration as a biomarker to exclude the presence of myocardial ischaemia in patients. Although there are a number of published studies detailing the clinical ut...
Autores principales: | Govender, R, De Greef, J, Delport, R, Vermaak, WJH, Becker, PJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650841/ https://www.ncbi.nlm.nih.gov/pubmed/18568173 |
Ejemplares similares
-
Does dipyridamole-induced ischaemia affect NT-proBNP secretion?
por: De Greef, Jacques, et al.
Publicado: (2007) -
NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia
por: De Greef, Jacques, et al.
Publicado: (2008) -
The effect of mebudipine on cardiac function and activity of the myocardial nitric oxide system in ischaemia–reperfusion injury in rats
por: Ghyasi, R, et al.
Publicado: (2011) -
Upper limb ischaemia: a South African single–centre experience
por: du Toit, Tinus, et al.
Publicado: (2018) -
Effects of enhanced external counterpulsation on anginal symptoms and improvements in objective measures of myocardial ischaemia
por: Yavari, M, et al.
Publicado: (2007)